Amneal Pharmaceuticals, Inc.·4

May 8, 4:29 PM ET

BUCHI J KEVIN 4

4 · Amneal Pharmaceuticals, Inc. · Filed May 8, 2026

Research Summary

AI-generated summary of this filing

Updated

Amneal (AMRX) Director Kevin Buchi Converts RSUs, Receives Award

What Happened

  • Director Buchi J. Kevin experienced the vesting/settlement of 34,819 restricted stock units (reported as a conversion/exercise of a derivative) on May 7, 2026 and, on May 6, 2026, was reported as acquiring a new award of 19,824 restricted stock units. The conversion shows 34,819 shares acquired and the same 34,819 shares disposed at $0 (derivative disposition), and the 19,824-unit award shows acquisition at $0. These transactions reflect awards/vesting and settlement activity rather than an open-market buy or sale.

Key Details

  • Transaction dates: May 6, 2026 (award of 19,824 RSUs); May 7, 2026 (conversion/settlement of 34,819 RSUs).
  • Prices/values reported: acquisitions at $0; the 34,819-share disposition reported at $0 (no cash proceeds shown).
  • Shares owned after transaction: not specified in the provided filing details.
  • Footnotes: F1—each restricted stock unit (RSU) is a contingent right to one share; F2—34,819 RSUs were originally granted May 6, 2025 and vested May 7, 2026; F3—vesting occurs per the grant’s schedule (first annual meeting or first anniversary rule).
  • Filing timeliness: Form 4 filed May 8, 2026 for May 6–7 transactions — appears to be filed within the usual 2-business-day window.

Context

  • These are derivative/RSU transactions: RSUs converted/settled into shares on vesting. The disposition reported at $0 commonly indicates shares were withheld or surrendered to cover tax withholding or similar employer-required withholdings (i.e., not an open-market sale). This type of insider filing documents compensation-related activity rather than a directional bet on the stock.

Insider Transaction Report

Form 4
Period: 2026-05-06
Transactions
  • Exercise/Conversion

    Class A Common Stock

    [F1]
    2026-05-07+34,81975,077 total
  • Exercise/Conversion

    Restricted Stock Units

    [F1][F2]
    2026-05-0734,8190 total
    Class A Common Stock (34,819 underlying)
  • Award

    Restricted Stock Units

    [F1][F3]
    2026-05-06+19,82419,824 total
    Class A Common Stock (19,824 underlying)
Holdings
  • Class A Common Stock

    (indirect: By Trust)
    262,072
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
  • [F2]On May 6, 2025, the reporting person was granted 34,819 restricted stock units vesting on May 7, 2026.
  • [F3]Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.
Signature
/s/ Denis Butkovic, Attorney-in-Fact|2026-05-08

Documents

1 file
  • 4
    wk-form4_1778272151.xmlPrimary

    FORM 4